Search details
1.
Consequences to patients, clinicians, and manufacturers when very serious adverse drug reactions are identified (1997-2019): A qualitative analysis from the Southern Network on Adverse Reactions (SONAR).
EClinicalMedicine
; 31: 100693, 2021 Jan.
Article
in English
| MEDLINE | ID: mdl-33554084
2.
Caveat Medicus: Clinician experiences in publishing reports of serious oncology-associated adverse drug reactions.
PLoS One
; 14(7): e0219521, 2019.
Article
in English
| MEDLINE | ID: mdl-31365527
Results
1 -
2
de 2
1
Next >
>>